EMEA-001908-PIP01-15

Key facts

Invented name
P/0114/2016
Active substance
  • levocetirizine (dihydrochloride)
  • Montelukast sodium
Therapeutic area
Pneumology-allergology
Decision number
P/0114/2016
PIP number
EMEA-001908-PIP01-15
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of asthma
Route(s) of administration
Oral use
Contact for public enquiries
Invest Bielany Sp. z o.o.
Poland
Tel. +48 734666650
Fax +48 228411671
E-mail: katarzyna.rawa@investbielany.pl
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

How useful was this page?

Add your rating